Status:
WITHDRAWN
The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early Cirrhosis
Lead Sponsor:
NYU Langone Health
Conditions:
Cirrhosis
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective study designed to examine the role of transient elastography as a predictor of clinical decompensation in patients with early cirrhosis. The study objective is to determine if ch...
Detailed Description
This is a prospective study designed to examine the role of transient elastography as a predictor of clinical decompensation in patients with early cirrhosis. The study objective is to determine if ch...
Eligibility Criteria
Inclusion
- Ambulatory patients with histologic or radiographic evidence of cirrhosis will be screened for participation in the study.
- Able to provide informed consent
- MELD score \<10
- No history of ascites, variceal bleeding, hepatorenal syndrome, overt hepatic encephalopathy.
Exclusion
- History of variceal bleeding, ascites, hepatorenal syndrome, or overt hepatic encephalopathy
- Inability to provide informed consent
- Body mass index (BMI)\>35
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02258048
Start Date
October 1 2014
End Date
October 1 2015
Last Update
March 10 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Medical Center
New York, New York, United States, 10016